CSS
SEM

Cubist Systematic Strategies’s Select Medical SEM Stock Holding History

Cubist Systematic Strategies’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-187,228
Closed -$2.84M – 3490
2025
Q2 		$2.84M Buy
187,228
+92,768
+98% +$1.45M 0.01% 1362
2025
Q1 		$1.58M Sell
94,460
-342,669
-78% -$6.31M 0.01% 1557
2024
Q4 		$8.24M Buy
+437,129
New +$8.43M 0.05% 563
2024
Q2 		– Sell
-159,442
Closed -$2.59M – 3890
2024
Q1 		$2.59M Buy
159,442
+97,116
+156% +$1.42M 0.01% 1441
2023
Q4 		$789K Sell
62,326
-138,361
-69% -$1.75M 0.01% 2229
2023
Q3 		$2.73M Sell
200,687
-86,076
-30% -$1.33M 0.02% 1146
2023
Q2 		$4.92M Buy
+286,763
New +$4.44M 0.03% 859
2022
Q3 		– Sell
-60,478
Closed -$770K – 4685
2022
Q2 		$770K Sell
60,478
-121,453
-67% -$1.56M ﹤0.01% 2693
2022
Q1 		$2.35M Sell
181,931
-149,402
-45% -$1.97M 0.02% 1354
2021
Q4 		$5.25M Buy
331,333
+167,803
+103% +$2.86M 0.05% 619
2021
Q3 		$3.19M Sell
163,530
-72,438
-31% -$1.44M 0.04% 722
2021
Q2 		$5.37M Sell
235,968
-65,534
-22% -$1.36M 0.06% 496
2021
Q1 		$5.54M Buy
301,502
+296,847
+6,377% +$4.87M 0.07% 400
2020
Q4 		$69K Sell
4,655
-102,379
-96% -$1.34M ﹤0.01% 2443
2020
Q3 		$1.2M Sell
107,034
-90,504
-46% -$891K 0.02% 1219
2020
Q2 		$1.57M Sell
197,538
-37,838
-16% -$313K 0.03% 936
2020
Q1 		$1.9M Buy
235,376
+66,647
+39% +$792K 0.05% 489
2019
Q4 		$2.12M Buy
168,729
+130,893
+346% +$1.41M 0.04% 718
2019
Q3 		$338K Sell
37,836
-1,584
-4% -$13.8K 0.01% 1493
2019
Q2 		$337K Sell
39,420
-138,251
-78% -$1.09M 0.01% 1721
2019
Q1 		$1.35M Buy
177,671
+77,924
+78% +$626K 0.04% 610
2018
Q4 		$825K Buy
99,747
+80,792
+426% +$773K 0.04% 657
2018
Q3 		$188K Sell
18,955
-19,499
-51% -$202K 0.01% 1429
2018
Q2 		$376K Sell
38,454
-144,110
-79% -$1.42M 0.02% 945
2018
Q1 		$1.7M Sell
182,564
-117,035
-39% -$1.11M 0.1% 265
2017
Q4 		$2.85M Buy
299,599
+130,642
+77% +$1.25M 0.15% 133
2017
Q3 		$1.75M Buy
+168,957
New +$1.56M 0.1% 213
2017
Q1 		– Sell
-2,561
Closed -$18K – 1831
2016
Q4 		$18K Buy
+2,561
New +$17.8K ﹤0.01% 1639
2016
Q3 		– Sell
-52,603
Closed -$308K – 1853
2016
Q2 		$308K Buy
52,603
+27,577
+110% +$183K 0.02% 1068
2016
Q1 		$159K Buy
25,026
+11,390
+84% +$61.1K 0.01% 1296
2015
Q4 		$88K Buy
+13,636
New +$85.3K 0.01% 1525
2015
Q3 		– Sell
-53,555
Closed -$467K – 1995
2015
Q2 		$467K Buy
53,555
+48,538
+967% +$408K 0.02% 995
2015
Q1 		$40K Sell
5,017
-21,329
-81% -$159K ﹤0.01% 1779
2014
Q4 		$204K Sell
26,346
-91,963
-78% -$671K 0.01% 1500
2014
Q3 		$767K Buy
118,309
+90,439
+325% +$698K 0.05% 587
2014
Q2 		$234K Buy
+27,870
New +$216K 0.01% 1082

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cubist Systematic Strategies's SEM Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Select Medical (SEM) in Q3 2025, closing a stake of 187,228 shares — an estimated $2.84M sold.

Cubist Systematic Strategies first reported a position in SEM in Q2 2014 and held it in 36 quarters. The position peaked at $8.24M in Q4 2024. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 187,228 Select Medical shares in Q3 2025, an estimated $2.84M.
  • Cubist Systematic Strategies first reported a position in Select Medical in Q2 2014 and held it in 36 quarters.
  • Cubist Systematic Strategies's Select Medical position peaked at $8.24M in Q4 2024.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.